EMAGine AG is a swiss medical device company established in February 2013. EMAGine uses the philosophy of “Science First, Marketing Second” to produce and launch innovative and high-quality products that will be accessible to healthcare professionals and institutions worldwide. The goal of EMAGine AG is to combat leading causes of global blindness by making corneal cross-linking technology accessible to all ophthalmologists. For this purpose, the team at EMAGine is currently developing the C-Eye© device and related product line to treat corneal infections by PACK-CXL and degenerations like keratoconus.